HomeNRXP • NASDAQ
add
NRX Pharmaceuticals Inc
Previous close
$2.41
Day range
$2.32 - $2.43
Year range
$1.58 - $3.84
Market cap
78.70M USD
Avg Volume
729.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 983.00K | — |
Operating expense | 5.17M | 42.24% |
Net income | 360.00K | 103.97% |
Net profit margin | 36.62 | — |
Earnings per share | — | — |
EBITDA | -4.55M | -25.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 12.96M | 254.86% |
Total liabilities | 28.89M | 7.51% |
Total equity | -15.94M | — |
Shares outstanding | 33.07M | — |
Price to book | — | — |
Return on assets | -82.18% | — |
Return on capital | 74.57% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 360.00K | 103.97% |
Cash from operations | -3.71M | -76.98% |
Cash from investing | — | — |
Cash from financing | 4.58M | 141.42% |
Net change in cash | 613.00K | 401.97% |
Free cash flow | — | — |
About
Founded
2015
Headquarters
Website
Employees
2
